Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study.

Halis Kaan AkturkFran DongJanet K Snell-BergeonKagan Ege KarakusViral N Shah

Published in: Journal of diabetes science and technology (2024)

Tirzepatide significantly reduced HbA1c and body weight in adults with T1D. A randomized controlled trial is needed to establish efficacy and safety of this drug in T1D.

Keyphrases

body weight
adverse drug
drug induced
emergency department